Sign up Australia
Proactive Investors - Run By Investors For Investors

G Medical Innovations a leading gainer on news of proposed Hong Kong listing of Chinese subsidiary

The shares were up 60% to an intra-day high of 29.7 cents on volume of more than 4.5 million.
ASX chart with arrow pointing up
The company specialises in mobile and e-health solutions and services

G Medical Innovations Holdings Ltd (ASX:GMV) is a leading ASX gainer on news of its intention to list its Chinese subsidiary on the main board of The Stock Exchange of Hong Kong Limited.

Shares were up 60% to an intra-day high of 29.7 cents on strong volume of more than 4.5 million.

Global investment bank engaged

The company has engaged global investment bank, UOB Kay Hian (Hong Kong) Ltd, as advisers for the listing of Guangzhou Yimei Innovative Medical Science and Technology Co Ltd (GYIMSTC).

Under the proposed listing, GYIMSTC would spin off from G Medical, with the ASX-listed company to retain not less than a 50% ownership stake.

The parent company currently holds 70% of GYIMSTC.

Intended listing in six to nine months

All parties are working towards a listing within the next six to nine months.

GYIMSTC oversees China-based manufacturing for G Medical, ensures all local certifications are met and has worked to build a strong relationship with the China Food and Drug Administration (CFDA).

It was the first company in 2018 to be granted acceptance to the Green Channel expedited Guangdong Provincial CFDA regulatory approval process.

Proven performer in China

This process was successfully applied to G Medical’s Prizma Medical Smartphone Case and will play a crucial role in the global commercialisation of this product.

Future innovative medical solutions in the development pipeline should also benefit from this process.

Funds raised from the listing will provide substantial working capital and fuel the research and development of innovative mobile health solutions and enable continued investment into state-of-the-art manufacturing facilities.

G Medical specialises in innovative next-generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams.

View full GMV profile View Profile

G Medical Innovations Holdings Ltd Timeline

Related Articles

Vault online software in the cloud image
August 08 2018
The company has achieved strong sales on the back of its risk and safety management software systems.
remote meeting
Wed
The acquisition of MeetingZone earlier this year has been called “transformational” by LoopUp bosses
1510592057_gas-pipeline.jpg
November 14 2017
In the quarter, the power and electromechanical segment contributed revenues of $16.7 million,

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use